BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12404777)

  • 21. [Psychopharmacological combination therapy in bipolar disorder].
    Quante A; van Hall F; Anghelescu I
    Fortschr Neurol Psychiatr; 2009 May; 77(5):252-62. PubMed ID: 19418383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticonvulsants in bipolar disorder.
    Singh V; Muzina DJ; Calabrese JR
    Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term response to carbamazepine: a retrospective study.
    Frankenburg FR; Tohen M; Cohen BM; Lipinski JF
    J Clin Psychopharmacol; 1988 Apr; 8(2):130-2. PubMed ID: 3372707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of anticonvulsants in the aftermath of mania.
    Cookson J; Elliott B
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):23-30. PubMed ID: 16551669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevention of relapse in bipolar disorder.
    Silverstone T; Romans S
    N Z Med J; 1995 Oct; 108(1009):397-8. PubMed ID: 7478331
    [No Abstract]   [Full Text] [Related]  

  • 30. Case study: carbamazepine treatment of juvenile-onset bipolar disorder.
    Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):335-8. PubMed ID: 10087696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rapid cycling in bipolar disorders].
    Knoppert-van der Klein EA; Hoogduin CA; Nolen WA
    Ned Tijdschr Geneeskd; 1994 Jan; 138(3):145-8. PubMed ID: 8295640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2007; 76(2):77-88. PubMed ID: 17230048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological interventions for bipolar youth: developmental considerations.
    DelBello MP; Kowatch RA
    Dev Psychopathol; 2006; 18(4):1231-46. PubMed ID: 17064436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombocytopenia associated with carbamazepine: a case series.
    Tohen M; Castillo J; Cole JO; Miller MG; de los Heros R; Farrer RJ
    J Clin Psychiatry; 1991 Dec; 52(12):496-8. PubMed ID: 1752850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case study: the use of melatonin in a boy with refractory bipolar disorder.
    Robertson JM; Tanguay PE
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):822-5. PubMed ID: 9183138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The carbamazepine hypersensitivity syndrome. Differential diagnosis and a representative case history].
    Elstner S; Sperling W
    Fortschr Neurol Psychiatr; 2000 Apr; 68(4):188-92. PubMed ID: 10803387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder.
    Malek-Ahmadi P; Hanretta AT
    Ann Pharmacother; 2004 Nov; 38(11):1852-4. PubMed ID: 15479776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.